Mahindra & Mahindra Limited
Financial trend (100/100) does the heavy lifting; momentum (29/100) is the drag.
Buy zoneSolvency riskMahindra & Mahindra Limited earns a Sell from StocksWizard, with a blended score of 40/100. At ₹3,107 it trades below our blended DCF and relative-multiples fair value of ₹4,797.6, about 54% upside to that estimate — we read it as undervalued by 54%. On 20.1x trailing earnings it sits cheaper than the Automobile and Auto Components median of about 39.5x. The price is about 17% below its 52-week high of ₹3,762.88 and 7% above the low of ₹2,900.64. Financial health scores 24/100, in the grey band on the Altman Z-score, with a Piotroski F-score of 4/9. The average analyst target of ₹4,115.49 implies about 32% upside across 35 analysts. It clears 6 of 13 investability checks, with durability 51, valuation 87 and momentum 29 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹3,838.08.
Analyst views
1-year price
EOD · 2026-09-1452-week range
-17.43% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Sell40Piotroski F-score 4/9 — quality of earnings & balance sheet.
Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
- Pass: ROE above 15%: 18.8%
- Fail: Low debt (D/E < 0.5): 1.25x
- Pass: Positive free cash flow
- Pass: Revenue growth > 10%: 31%
- Pass: Earnings growing: 45%
- Fail: Net margin ≥ 10%: 8.5%
- Fail: Current ratio > 1.5: 1.27
- Pass: Below our fair value
- Pass: Margin of safety ≥ 20%
- Fail: Above 200-day average
- Fail: Above 50-day average
- No data: Positive 1-year return
- Fail: Altman Z in safe zone: Z 1.94
- Fail: Piotroski ≥ 7: 4/9
Quarterly results
Annual financials
Shareholding
- Promoter25.3%
- Institutions53.0%
- Public & other21.7%
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
Bull case vs bear case
Bull case
Strengths
- Strong return on equity (18.8%).
Opportunities
- Earnings growing (45% YoY).
- Revenue growing (31% YoY).
- Trading in our value buy zone versus sector peers.
- Trades ~54% below our estimated fair value.
Bear case
Weaknesses
- High debt relative to equity.
- Price below its 200-day moving average (downtrend).
About Mahindra & Mahindra Limited
Mahindra & Mahindra Limited provides mobility products and farm solutions in India and internationally. It operates through five segments: Automotive; Farm Equipment; Auto Investments; Farm Investments; and Investments in Industrial Businesses and Consumer Services. The company offers commercial vehicles, trucks, buses, vans, passenger cars, utility vehicles, and electric vehicles (EV), as well as motorcycles; aero and defense products; offers construction equipment, such as
Mahindra & Mahindra Limited — frequently asked questions
Is Mahindra & Mahindra Limited a buy, hold or sell?
StocksWizard currently rates Mahindra & Mahindra Limited (M&M) a Sell, based on a blended score of 40/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
What is Mahindra & Mahindra Limited's fair value?
Our blended DCF and relative-valuation model estimates Mahindra & Mahindra Limited's fair value at about ₹4,797.6, versus a current price of ₹3,107 — roughly 54% upside. On that basis the stock looks undervalued by 54%.
Is Mahindra & Mahindra Limited financially healthy?
Mahindra & Mahindra Limited scores 24/100 on our financial-health model, placing it in the grey band on the Altman Z-score, with a Piotroski F-score of 4/9.
How has Mahindra & Mahindra Limited's share price performed?
Mahindra & Mahindra Limited is roughly flat over three months, and last traded at ₹3,107. Past performance doesn't predict future returns.
More in Automobile and Auto Components
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.